Does Dr. RANIA ABDEL-RAHMAN have financial conflicts of interest?

Dr. RANIA ABDEL-RAHMAN (M.D.) has received a total of $260 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $260 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RANIA ABDEL-RAHMAN?

According to CMS Open Payments data, Dr. RANIA ABDEL-RAHMAN received funding from BAYER HEALTHCARE PHARMACEUTICALS ($121), ASTRAZENECA PHARMACEUTICALS ($98), and CORMEDIX ($21).

Does Dr. RANIA ABDEL-RAHMAN receive research grants or speaking fees?

Dr. RANIA ABDEL-RAHMAN has received $260 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RANIA ABDEL-RAHMAN

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: JACKSONVILLE, FL 32216

NPI Number: 1013059211

LIFETIME INDUSTRY VALUE

$260

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDEL-RAHMAN is a verified Internal Medicine, Nephrology practitioner based in JACKSONVILLE, FL.

Between 2021 and 2024, Dr. ABDEL-RAHMAN had an overall industry promotional and research financial footprint of $260 as recorded in the federal CMS Open Payments database.

$260 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDEL-RAHMAN's primary funding source is BAYER HEALTHCARE PHARMACEUTICALS, which accounts for $121 (representing 46.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BAYER HEALTHCARE PHARMACEUTICALS

Rank 1

$121

46.5%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$98

37.8%

CORMEDIX

Rank 3

$21

8.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.